Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Asensus Surgical, Inc. (ASXC : AMEX)
 
 • Company Description   
Asensus Surgical Inc. is a medical device company which is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery(TM). Asensus Surgical Inc., formerly known as TransEnterix Inc., is based in RESEARCH TRIANGLE PARK, N.C.

Number of Employees: 167

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.42 Daily Weekly Monthly
20 Day Moving Average: 3,205,156 shares
Shares Outstanding: 236.46 (millions)
Market Capitalization: $99.36 (millions)
Beta: 1.65
52 Week High: $3.75
52 Week Low: $0.35
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -17.96% -7.61%
12 Week -44.71% -39.22%
Year To Date -62.14% -54.98%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1 TW ALEXANDER DRIVE SUITE 160
-
DURHAM,NC 27703
USA
ph: 919-765-8400
fax: 919-765-8459
invest@transenterix.com http://www.asensus.com
 
 • General Corporate Information   
Officers
Anthony Fernando - President; Chief Executive Officer and a Director
David B. Milne - Chairman
Shameze Rampertab - Executive Vice President and Chief Financial Offic
Andrea Biffi - Director
Jane H. Hsaio - Director

Peer Information
Asensus Surgical, Inc. (ABMD)
Asensus Surgical, Inc. (DMDS)
Asensus Surgical, Inc. (CPWY.)
Asensus Surgical, Inc. (EQUR)
Asensus Surgical, Inc. (ECIA)
Asensus Surgical, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 04367G103
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 236.46
Most Recent Split Date: 12.00 (0.08:1)
Beta: 1.65
Market Capitalization: $99.36 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.08 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.31 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.66
Price/Cash Flow: -
Price / Sales: 13.77
EPS Growth
vs. Year Ago Period: -16.67%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: -48.82%
vs. Previous Quarter: -56.95%
ROE
03/31/22 - -34.04
12/31/21 - -29.22
09/30/21 - -30.34
ROA
03/31/22 - -31.03
12/31/21 - -26.75
09/30/21 - -27.40
Current Ratio
03/31/22 - 13.72
12/31/21 - 11.50
09/30/21 - 14.31
Quick Ratio
03/31/22 - 12.66
12/31/21 - 10.63
09/30/21 - 13.04
Operating Margin
03/31/22 - -822.27
12/31/21 - -667.52
09/30/21 - -712.24
Net Margin
03/31/22 - -890.51
12/31/21 - -758.77
09/30/21 - -879.52
Pre-Tax Margin
03/31/22 - -885.70
12/31/21 - -756.04
09/30/21 - -881.51
Book Value
03/31/22 - 0.64
12/31/21 - 0.72
09/30/21 - 0.77
Inventory Turnover
03/31/22 - 0.93
12/31/21 - 1.00
09/30/21 - 0.82
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©